|
KR102145197B1
|
|
Use of l-nucleosides for treating corona virus
|
|
KR101827744B1
|
|
Method for preparing tolimidone on large scale
|
|
KR20160110258A
|
|
Antiviral composition comprising Tenofovir Disoproxil Succinate and methods for preparing the same
|
|
KR20160065496A
|
|
Recrystallization method for purification of phenoxy-2(1h)-pyrimidinone analogues
|
|
WO2011145808A2
|
|
Composition for treating chronic hepatitis b, containing clevudine and adefovir dipivoxil
|
|
KR20100127180A
|
|
Compositions for the treatment of chronic hepatitis b containing clevudine and adefovir dipivoxil
|
|
KR20110117428A
|
|
1-(2'-DEOXY-2'-FLUORO-β-L-ARABINOFURANOSYL)THYMINE(CLEVUDINE) MONOPHOSPHATE OR ITS SODIUM SALT FOR THE TREATMENT OF HEPATITIS B VIRUS
|
|
KR20110008773A
|
|
Sustained release mini-tablet containing doxophylline and preparation method thereof
|
|
KR20080107083A
|
|
Doxophylline sustained release mini-tablet
|
|
KR20080040540A
|
|
Anti-obesity composition containing dietary fiber and lipase inhibitor, and method for preparing the same
|
|
KR20080052827A
|
|
Improved process for the preparation of clevudine as anti-hbv agent
|
|
KR100815029B1
|
|
Doxophylline sustained-release dosage form
|
|
KR20070025426A
|
|
COMPOSITION FOR INHIBITING LIVER FIBROSIS AND CIRRHOSIS CONTAINING D-(+)-alpha;-LIPOIC ACID TROMETHAMINE SALT
|
|
KR20060079063A
|
|
Composition for protecting hepatocyte and liver containing silymarin and lipoic acid or its salts
|
|
KR0143452B1
|
|
Modified process of preparation for esters
|
